Imazol Paste (Clotrimazole)

Clotrimazole works by inhibiting the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesizing ergosterol, a key component of the fungal cell membrane. Disruption of ergosterol production weakens the membrane, leading to increased permeability and ultimately fungal cell death.

The specific amount and frequency of Imazol Paste application are determined by the prescribing healthcare professional based on the infection type, severity, patient age and skin area involved. Patients should follow the prescriber’s instructions and the product label for optimal results.

Safety data for clotrimazole topical use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential risks and benefits with their healthcare provider before using Imazol Paste.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Imazol Paste delivers clotrimazole, an azole class antifungal, which is effective against a broad spectrum of dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, clotrimazole generally has a similar efficacy for mild to moderate infections but may require longer treatment duration. Choice of therapy depends on infection type, patient tolerance and clinician preference.

Imazol Paste should be stored at room temperature, below 25 °C. Keep the tube tightly closed in its original packaging, protect it from moisture, direct sunlight and excessive heat to maintain product stability.

Clean and dry the affected skin area before use. Apply a thin layer of the paste to the lesion and surrounding skin, gently rubbing it in. The usual practice is to apply twice daily, or as directed by the prescriber, for the full course of therapy even if symptoms improve.

While generally well tolerated, serious adverse reactions can include allergic contact dermatitis, severe skin swelling, urticaria, or, in rare cases, anaphylaxis. If any signs of a severe allergic reaction such as difficulty breathing, swelling of the face or throat, or widespread rash occur, discontinue use and seek immediate medical attention.

Imazol Paste should be avoided in individuals with a known hypersensitivity to clotrimazole or any other component of the formulation. It is also not recommended for use on extensive broken skin, mucous membranes, or in infants younger than one month unless specifically advised by a healthcare professional.